HOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Beats Revenue for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

HOWL stock results show that Werewolf Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

The post HOWL Stock Earnings: Werewolf Therapeutics Misses EPS, Beats Revenue for Q2 2024 appeared first on InvestorPlace.

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”